Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05698381 · ClinicalTrials.gov registry record · NA
Daily Vinegar Ingestion and Metabolic Health
A NA study, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT05698381: Completed NA study, sponsored by Arizona State University.
NCT05698381 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05698381, a NA study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if vinegar ingestion promotes beneficial changes to metabolic health parameters in healthy, overweight adults.
Primary Outcome
Patient Health Questionnaire (PHQ-9); scores range from 0 (none-minimal) to 27 (severe)
Interventions
- DIETARY_SUPPLEMENT Liquid vinegar
- DIETARY_SUPPLEMENT Vinegar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2023-08-15 |
| Phase | NA |
What the finished NCT05698381 record still lists
NCT05698381 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Liquid vinegar is the first listed.
NCT05698381 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05698381 about?
NCT05698381 is a clinical study titled "Daily Vinegar Ingestion and Metabolic Health". The purpose of this study is to determine if vinegar ingestion promotes beneficial changes to metabolic health parameters in healthy, overweight adults.
What is the current status of trial NCT05698381?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2023-02-01. Estimated completion is 2023-08-15.
What interventions are being tested in trial NCT05698381?
The interventions under investigation include: Liquid vinegar (DIETARY_SUPPLEMENT), Vinegar pill (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05698381?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05698381's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI